These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 4389278)
41. Enzymatic N-methylation of phenelzine catalyzed by phenylethanolamine N-methyltransferase. Yu PH; Davis BA; Durden DA Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):307-12. PubMed ID: 1871333 [TBL] [Abstract][Full Text] [Related]
42. Enzymatic N-methylation of phenelzine catalyzed by methyltransferases from adrenal and other tissues. Yu PH; Davis BA; Durden DA Drug Metab Dispos; 1991; 19(4):830-4. PubMed ID: 1680662 [TBL] [Abstract][Full Text] [Related]
43. [Relation between the anti-inflammatory effect and inhibiting activity of monoaminoxidase inhibitors]. Trinus FP; Riabukha TK Farmakol Toksikol; 1973; 36(1):84-9. PubMed ID: 4685161 [No Abstract] [Full Text] [Related]
45. Effect of psychoactive drugs on in vivo metabolism of 14C-histamine in mouse brain. Schayer RW; Reilly MA Arch Int Pharmacodyn Ther; 1973 May; 203(1):123-9. PubMed ID: 4725329 [No Abstract] [Full Text] [Related]
50. Interaction of D-cycloserine with the action of some monoamine oxidase inhibitors. Vítek V; Rysánek K Biochem Pharmacol; 1965 Oct; 14(10):1417-24. PubMed ID: 4379549 [No Abstract] [Full Text] [Related]
51. Electroshock, liver serotonin level and tryptophan pyrrolase activity in rats. Sato T; Iwamoto T Jpn J Pharmacol; 1968 Mar; 18(1):89-92. PubMed ID: 4386207 [No Abstract] [Full Text] [Related]
52. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid. Maître L J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494 [No Abstract] [Full Text] [Related]
53. The effect of monoamine oxidase inhibitors on conjugation. Hargreaves T Experientia; 1968 Feb; 24(2):157-8. PubMed ID: 5643811 [No Abstract] [Full Text] [Related]
54. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases. Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498 [No Abstract] [Full Text] [Related]
55. Deuterium isotope effect of phenelzine on the inhibition of rat liver mitochondrial monoamine oxidase activity. Yu PH; Tipton KF Biochem Pharmacol; 1989 Dec; 38(23):4245-51. PubMed ID: 2597196 [TBL] [Abstract][Full Text] [Related]
56. The influence of some MAO inhibitors and neuroleptics on enzymes concerned in GABA metabolism. Simánĕ Z; Kraus P Act Nerv Super (Praha); 1968 Oct; 10(3):331. PubMed ID: 4387433 [No Abstract] [Full Text] [Related]
57. Monoamine oxidase inhibitors, combined with thymoleptics: Are they really unusable for human beings? Bartonícek VJ Pharmacology; 1970; 4(2):80-90. PubMed ID: 5528371 [No Abstract] [Full Text] [Related]
58. Effect of monoamine oxidase inhibition on biliary excretion of metabolites of norepinephrine by isolated rat liver. Zimon RP; Tyce GM; Flock EV; Sheps SG; Owen CA J Pharmacol Exp Ther; 1967 Jul; 157(1):89-95. PubMed ID: 4382102 [No Abstract] [Full Text] [Related]
59. Inhibition by hydrazine, phenelzine and pargyline of insulin release from rat pancreas. Aleyassine H; Lee SH Endocrinology; 1971 Jul; 89(1):125-9. PubMed ID: 4930774 [No Abstract] [Full Text] [Related]
60. MONOAMINE OXIDASE INHIBITORS: A REVIEW. HASTINGS GE J Kans Med Soc; 1963 Sep; 64():409-18. PubMed ID: 14047794 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]